Jazz Pharmaceuticals

125.00
0.85 (0.68%)
At close: Apr 01, 2025, 3:59 PM
123.34
-1.33%
Pre-market: Apr 02, 2025, 05:49 AM EDT

Jazz Pharmaceuticals Cash Flow Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05
Net Income 560.12M 414.83M -224.06M -329.67M 238.62M 523.37M 447.1M 487.85M 396.83M 329.53M 57.33M 216.31M 288.59M 124.98M 32.78M -6.84M -184.34M -138.83M -59.39M -85.16M
Depreciation & Amortization 660.07M 638.7M 629.47M 552.48M 278.25M 370.16M 216.73M 165.15M 113.78M 108.06M 133.68M 82.09M 74.23M 7.83M 8.71M 9.1M 15.03M 10.53M 10.31M 5.44M
Stock-Based Compensation 248.04M 226.84M 222M 189.01M 121M 110.56M 102.44M 106.9M 98.77M 91.55M 69.64M 44.55M 23.01M 20.7M 8.22M 5.96M 8.11M 6.06M n/a n/a
Other Working Capital -56.65M -214.04M 160.91M 36.62M 2.68M -29.74M 64.89M 22.94M 19.55M 14.74M 49.2M -28.68M 5.16M 5.32M 4.71M -15.74M 3.11M 29.88M 15.92M 3.07M
Other Non-Cash Items 212.72M 276.29M 926.92M 345.44M 484.15M 159.01M 98.16M 132.01M 45.04M 70.12M 239.98M 31.72M -17.05M 125.38M 2.41M 14K 2.06M 25.56M -23.67M 24.71M
Deferred Income Tax -208.33M -260.22M -292.25M 69.2M -136.94M -236.61M -88.81M -225.59M -41.16M -61.21M -43.42M -10.1M -113.86M -123.7M 12.57M n/a 26.81M -11.91M n/a n/a
Change in Working Capital -76.72M -204.44M 9.9M -47.95M -85.44M -150.08M 23.29M 26.77M -22.72M -6.11M -51.44M -80.96M -5.16M -3.59M -5.81M -24.11M 2.1M 27.5M 15.4M 2.85M
Operating Cash Flow 1.4B 1.09B 1.27B 778.51M 899.65M 776.4M 798.9M 693.09M 590.54M 531.94M 405.76M 283.62M 249.75M 151.6M 58.87M -15.88M -130.23M -81.09M -57.35M -52.16M
Capital Expenditures -48.07M -23.96M -498.19M -45.53M -379.25M -182.34M -131.47M -113.95M -181.58M -35.96M -238.97M -11.28M -22.48M -5.78M -4.73M -6.05M -28.74M -3.15M -1.68M -1.41M
Acquisitions n/a n/a 53M -6.23B -364.25M -142.2M 111.1M 85M -1.5B 33.7M -828.68M n/a -448.61M -4.5M n/a n/a n/a 10.15M 150K -146.12M
Purchase of Investments n/a -390.1M -61.04M -26.82M -2.4B -917.1M -1.17B -385M -65.28M n/a n/a n/a -37.44M -79.89M n/a n/a n/a -10.85M -1.71M n/a
Sales Maturities Of Investments n/a 270M 60M 1.09B 1.75B 985M 855M 230M 173.75M n/a n/a n/a 113.23M 4.03M 2.59M 1M 3.44M 10.85M 1.71M 5.95M
Other Investing Acitivies -470.13M -19M -444.15M 1.05B 378.51M 101.33M -63.2M -85M -173.75M 33.7M -202.63M -6.29M -389.32M 4.9M -1.41M -1.07M 13.36M -1.66M 25K -12.18M
Investing Cash Flow -508.19M -163.06M -446.23M -5.21B -1.01B -155.3M -394.49M -268.95M -1.75B -2.25M -1.07B -11.28M -395.29M -81.23M -2.14M -6.12M -11.94M 5.34M -1.51M -153.75M
Debt Repayment 374.77M -31M -582.01M 3.87B 591.81M -33.39M -25.72M -326.7M 816.34M -167.12M 884.86M 87.52M 439.04M -49.5M -89.93M n/a 38.45M 1.27M 2.19M n/a
Common Stock Repurchased -311.43M -269.76M -54K -35.6M -146.54M -301.45M -523.67M -98.8M -278.3M -61.55M -42.22M -136.48M -25.3M n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies -42.82M -4.49M -45.44M 99.66M 99.68M -16.74M -23.08M 16.39M 24.17M -26.18M -111.74M 30.53M 9.49M n/a 5.59M 5.91M 1.17M n/a 15M 15M
Financial Cash Flow 20.52M -305.25M -529.49M 3.97B 528.07M -293.75M -479.13M -409.11M 540.99M -214.32M 712.88M -24.03M 448.53M -33.08M -27.53M 12.69M 64.13M 99.75M 117.19M 192.85M
Net Cash Flow 906.55M 624.83M 290.03M -466.32M 420.43M 327.72M -76.41M 20.07M -622.82M 304.74M 47.54M 249.31M 305.12M 37.28M 29.2M -9.31M -78.04M 24M 58.33M -13.06M
Free Cash Flow 1.35B 1.07B 773.78M 732.98M 520.39M 594.07M 667.43M 579.14M 408.95M 495.99M 166.79M 272.34M 227.28M 145.82M 54.14M -21.93M -158.97M -84.24M -59.03M -53.58M